1 |
Effects of a probiotic suspension Symprove™ on a rat early-stage Parkinson’s disease model |
|
|
| Marco Sancandi, Carmen De Caro, Neringa Cypaite, Nadia Marascio, Carmen Avagliano, Carmela De Marco, Emilio Russo, Andrew Constanti, Audrey Mercer |
|
| Frontiers in Aging Neuroscience. 2023; 14 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
2 |
Curcumin-Based Nanomedicines in the Treatment of Inflammatory and Immunomodulated Diseases: An Evidence-Based Comprehensive Review |
|
|
| Lucas Fornari Laurindo, Gabriel Magno de Carvalho, Bárbara de Oliveira Zanuso, Maria Eduardo Figueira, Rosa Direito, Ricardo de Alvares Goulart, Daiene Santos Buglio, Sandra Maria Barbalho |
|
| Pharmaceutics. 2023; 15(1): 229 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
3 |
Role of Neddylation in Neurodegenerative Diseases |
|
|
| Manoj Govindarajulu, Sindhu Ramesh, Tharanth Shankar, Murali Krishna Kora, Timothy Moore, Muralikrishnan Dhanasekaran |
|
| NeuroSci. 2022; 3(4): 533 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
4 |
Role of SUMOylation in Neurodegenerative Diseases |
|
|
| Nicolas Mandel, Nitin Agarwal |
|
| Cells. 2022; 11(21): 3395 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
5 |
MPC-STANet: Alzheimer’s Disease Recognition Method Based on Multiple Phantom Convolution and Spatial Transformation Attention Mechanism |
|
|
| Yujian Liu, Kun Tang, Weiwei Cai, Aibin Chen, Guoxiong Zhou, Liujun Li, Runmin Liu |
|
| Frontiers in Aging Neuroscience. 2022; 14 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
6 |
Advances and Challenges in Intranasal Delivery of Antipsychotic Agents Targeting the Central Nervous System |
|
|
| Manisha Pandey, Neha Jain, Jovita Kanoujia, Zahid Hussain, Bapi Gorain |
|
| Frontiers in Pharmacology. 2022; 13 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
7 |
Ganoderic Acid A targeting
leucine-rich repeat kinase 2
involved in Parkinson's disease–A computational study
|
|
|
| Faizan Ahmad |
|
| AGING MEDICINE. 2022; |
|
| [Pubmed] [Google Scholar] [DOI] |
|
8 |
Novel insights into the role of circular
RNAs
in Parkinson disease: An emerging renaissance in the management of neurodegenerative diseases
|
|
|
| Zahra Dorostgou, Negar Yadegar, Zeynab Dorostgou, Fariborz Khorvash, Omid Vakili |
|
| Journal of Neuroscience Research. 2022; |
|
| [Pubmed] [Google Scholar] [DOI] |
|
9 |
Involvement of the G-Protein-Coupled Estrogen Receptor-1 (GPER) Signaling Pathway in Neurodegenerative Disorders: A Review |
|
|
| Shubham Upadhayay, Rishav Gupta, Surbhi Singh, Maroti Mundkar, Gursewak Singh, Puneet Kumar |
|
| Cellular and Molecular Neurobiology. 2022; |
|
| [Pubmed] [Google Scholar] [DOI] |
|
10 |
Effects of radiation exposure on brain health: a state of the art and new challenges |
|
|
| Jayalakshmi Jayan, Harsha Roshi, Fathima Farzana Perumbilly Ashraf, Parvathy G. Nair, Aparna Vijayakumar, Aathira Sujathan Nair, Leena K. Pappachen, Mohamed A. Abdelgawad, Della Grace Thomas Parambi, Lotfi Aleya, Bijo Mathew |
|
| Environmental Science and Pollution Research. 2022; |
|
| [Pubmed] [Google Scholar] [DOI] |
|
11 |
Chemically induced models of Parkinson's disease |
|
|
| Thilaga Thirugnanam, Kirankumar Santhakumar |
|
| Comparative Biochemistry and Physiology Part C: Toxicology & Pharmacology. 2022; 252: 109213 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
12 |
Amelioration of oxidative stress utilizing nanoemulsion loaded with bromocriptine and glutathione for the management of Parkinson's disease |
|
|
| Muhammad Usama Ashhar, Preeti Vyas, Divya Vohora, Pravat Kumar Sahoo, Kuldeep Nigam, Shweta Dang, Javed Ali, Sanjula Baboota |
|
| International Journal of Pharmaceutics. 2022; 618: 121683 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
13 |
Parkinson’s disease diagnosis using neural networks: Survey and comprehensive evaluation |
|
|
| M. Tanveer, A.H. Rashid, Rahul Kumar, R. Balasubramanian |
|
| Information Processing & Management. 2022; 59(3): 102909 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
14 |
Mass spectrometry-based proteomics analysis of human substantia nigra from Parkinson's disease patients identifies multiple pathways potentially involved in the disease |
|
|
| Yura Jang, Olga Pletnikova, Juan C. Troncoso, Alexander Y. Pantelyat, Ted M. Dawson, Liana S. Rosenthal, Chan Hyun Na |
|
| Molecular & Cellular Proteomics. 2022; : 100452 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
15 |
Rotenone induces regionally distinct a-synuclein protein aggregation and activation of glia prior to loss of dopaminergic neurons in C57Bl/6 mice |
|
|
| Savannah M. Rocha, Collin M. Bantle, Tawfik Aboellail, Debotri Chatterjee, Richard J. Smeyne, Ronald B. Tjalkens |
|
| Neurobiology of Disease. 2022; 167: 105685 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
16 |
Quantitative Transcranial Sonography Evaluation of Substantia Nigra Hyperechogenicity Is Useful for Predicting Levodopa-Induced Dyskinesia in Parkinson Disease |
|
|
| Jia-Hui Yan, Kai Li, Yi-Lun Ge, Wen Li, Pu-Zhi Wang, Hong Jin, Jin-Ru Zhang, Jing Chen, Fen Wang, Ya-Ping Yang, Ying-Chun Zhang, Dan Li, Cheng-Jie Mao, Chun-Feng Liu |
|
| Ultrasound in Medicine & Biology. 2022; |
|
| [Pubmed] [Google Scholar] [DOI] |
|
17 |
Endosomal recycling protein Rab11 in Parkin and Pink1 signaling in Drosophila model of Parkinson's disease |
|
|
| Pooja Rai, Jagat Kumar Roy |
|
| Experimental Cell Research. 2022; : 113357 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
18 |
Glycolysis: The Next Big Breakthrough in Parkinson’s Disease |
|
|
| Unaiza Naeem, Abdul Rehman Arshad, Areesha Jawed, Farea Eqbal, Laiba Imran, Zayeema Khan, Farhat Ijaz |
|
| Neurotoxicity Research. 2022; |
|
| [Pubmed] [Google Scholar] [DOI] |
|
19 |
Western and ketogenic diets in neurological disorders: can you tell the difference? |
|
|
| Karl John Habashy, Fatima Ahmad, Stanley Ibeh, Sarah Mantash, Fatima Kobeissy, Hawraa Issa, Ralph Habis, Ali Tfaily, Sanaa Nabha, Hayat Harati, Mohammad Amine Reslan, Yara Yehya, Chloe Barsa, Abdullah Shaito, Kazem Zibara, Ahmed F El-Yazbi, Firas H Kobeissy |
|
| Nutrition Reviews. 2022; |
|
| [Pubmed] [Google Scholar] [DOI] |
|
20 |
Effects of Baduanjin exercise on motor function, balance and gait in Parkinson’s disease: a systematic review and meta-analysis |
|
|
| Jinghui Lai, Yangfan Cai, Liyan Yang, Min Xia, Xi Cheng, Ying Chen |
|
| BMJ Open. 2022; 12(11): e067280 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
21 |
Co-Application of C16 and Ang-1 Improves the Effects of Levodopa in Parkinson Disease Treatment |
|
|
| Xiao-Xiao Fu, Jin Wang, Hua-Ying Cai, Hong Jiang, Jin-Zhan Jiang, Hao-Hao Chen, Shu Han |
|
| Journal of Inflammation Research. 2022; Volume 15: 3797 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
22 |
A Systematic Review of Machine Learning Based Gait Characteristics in
Parkinson’s Disease |
|
|
| Pooja Sharma, SK Pahuja, Karan Veer |
|
| Mini-Reviews in Medicinal Chemistry. 2022; 22(8): 1216 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
23 |
Effect of Shenfu injection on the level of acetylcholine in acute liver injury of young rats with sepsis |
|
|
| Jian WU, Wei YU, Jianping ZHU, Yun LIU, Yanhong SHEN, Mengsi SUN, Guoqiang JIN |
|
| Minerva Gastroenterology. 2022; 68(3) |
|
| [Pubmed] [Google Scholar] [DOI] |
|
24 |
Clinical efficacy of probiotics in the treatment of constipation in Parkinson's patients |
|
|
| Ting YAN, Jinzi SHI, Xiang LI |
|
| Minerva Gastroenterology. 2022; 68(3) |
|
| [Pubmed] [Google Scholar] [DOI] |
|
25 |
Application of neurotoxin- and pesticide-induced animal models of Parkinson’s disease in the evaluation of new drug delivery systems |
|
|
| Yaquelyn Casanova, Sofia Negro, Emilia Barcia |
|
| Acta Pharmaceutica. 2022; 72(1): 35 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
26 |
The recent guidelines for pharmacotherapy of Parkinson’s Disease |
|
|
| Tomasz Karabin, Grazyna Biala, Marta Kruk-Slomka |
|
| Current Issues in Pharmacy and Medical Sciences. 2022; 0(0) |
|
| [Pubmed] [Google Scholar] [DOI] |
|
27 |
Depression and Quality of Life of Parkinson’s disease patients – A hospital-based cross-sectional study |
|
|
| Maanasa Rajagopalan, Lakshmi Narasimhan Ranganathan, S. Valarmathi, Srinivas Govindarajulu, Sudha Seshayyan |
|
| Indian Journal of Medical Sciences. 2022; 0: 1 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
28 |
The Positive Role and Mechanism of Herbal Medicine in Parkinson’s Disease |
|
|
| Rong Yin, Jie Xue, Yanfeng Tan, Chuantao Fang, Chunchun Hu, Qian Yang, Xinyu Mei, Dashi Qi, Silvana Hrelia |
|
| Oxidative Medicine and Cellular Longevity. 2021; 2021: 1 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
29 |
Cross-talks among GBA mutations, glucocerebrosidase, and a-synuclein in GBA-associated Parkinson’s disease and their targeted therapeutic approaches: a comprehensive review |
|
|
| Tapan Behl, Gagandeep Kaur, Ovidiu Fratila, Camelia Buhas, Claudia Teodora Judea-Pusta, Nicoleta Negrut, Cristiana Bustea, Simona Bungau |
|
| Translational Neurodegeneration. 2021; 10(1) |
|
| [Pubmed] [Google Scholar] [DOI] |
|
30 |
The impact of clinical scales in Parkinson’s disease: a systematic review |
|
|
| Nikita Aggarwal, Barjinder Singh Saini, Savita Gupta |
|
| The Egyptian Journal of Neurology, Psychiatry and Neurosurgery. 2021; 57(1) |
|
| [Pubmed] [Google Scholar] [DOI] |
|
31 |
Effects of domotics on cognitive, social and personal functioning in patients with Parkinson’s disease: A pilot study |
|
|
| Desiree Latella, Maria Grazia Maggio, Giuseppa Maresca, Adriana Andaloro, Smeralda Anchesi, Valentina Pajno, Rosaria De Luca, Giuseppe Di Lorenzo, Alfredo Manuli, Rocco Salvatore Calabrò |
|
| Assistive Technology. 2021; : 1 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
32 |
Association of Multiple Dopamine D3 Receptor Gene 3'UTR Polymorphisms with Susceptibility to Parkinson's Disease and Clinical Efficacy of Piribedil Therapy |
|
|
| Rongbo Zhang, Jing Li, You Wu, Shunli Liang, Linsheng Xu |
|
| Genetic Testing and Molecular Biomarkers. 2021; 25(1): 20 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
33 |
Automatic and non-invasive Parkinson’s disease diagnosis and severity rating using LSTM network |
|
|
| Balaji E., Brindha D., Vinodh Kumar Elumalai, Vikrama R. |
|
| Applied Soft Computing. 2021; 108: 107463 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
34 |
Therapeutic Regime to Ameliorate Quality of Life in Patients with Parkinson’s Disease |
|
|
| Nidhi Sharma, Manpreet Kaur, Anju Goyat, Priyanka Sharma, Adarsh Kumar Srivastav, B. K. Agrawal |
|
| Physical & Occupational Therapy In Geriatrics. 2021; : 1 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
35 |
Title of the manuscript: Mechanistic insights into chalcone butein-induced inhibition of a-synuclein fibrillation: Biophysical and insilico studies |
|
|
| Tinku, Harshad Paithankar, Ankita R. Rane, Ramakrishna V. Hosur, Sinjan Choudhary |
|
| Journal of Molecular Liquids. 2021; 334: 116105 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
36 |
Mutational Impact on “in-Between-Ring” (IBR) Domain of PARKIN on Protein Stability and Function |
|
|
| Sima Biswas, Angshuman Bagchi |
|
| Applied Biochemistry and Biotechnology. 2021; 193(6): 1603 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
37 |
Recent Progress in Non-motor Features of Parkinson’s Disease with a Focus on Circadian Rhythm Dysregulation |
|
|
| Yufei Liu, Long Niu, Xinyao Liu, Cheng Cheng, Weidong Le |
|
| Neuroscience Bulletin. 2021; 37(7): 1010 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
38 |
The Histaminergic System in Neuropsychiatric Disorders |
|
|
| Li Cheng, Jiaying Liu, Zhong Chen |
|
| Biomolecules. 2021; 11(9): 1345 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
39 |
Astragaloside IV Protects 6-Hydroxydopamine-Induced SH-SY5Y Cell Model of Parkinson’s Disease via Activating the JAK2/STAT3 Pathway |
|
|
| ZhengHu Xu, Dongfeng Yang, Xiaojing Huang, Huai Huang |
|
| Frontiers in Neuroscience. 2021; 15 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
40 |
Local Translation in Nervous System Pathologies |
|
|
| María Gamarra, Aida de la Cruz, Maite Blanco-Urrejola, Jimena Baleriola |
|
| Frontiers in Integrative Neuroscience. 2021; 15 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
41 |
Neuroprotective effects of oleuropein: Recent developments and contemporary research |
|
|
| Masood Sadiq Butt, Urwa Tariq, Iahtisham-Ul-Haq, Ambreen Naz, Muhammad Rizwan |
|
| Journal of Food Biochemistry. 2021; |
|
| [Pubmed] [Google Scholar] [DOI] |
|
42 |
Nuclear and Mitochondrial Genome, Epigenome and Gut Microbiome: Emerging Molecular Biomarkers for Parkinson’s Disease |
|
|
| Gleyce Fonseca Cabral, Ana Paula Schaan, Giovanna C. Cavalcante, Camille Sena-dos-Santos, Tatiane Piedade de Souza, Natacha M. Souza Port’s, Jhully Azevedo dos Santos Pinheiro, Ândrea Ribeiro-dos-Santos, Amanda F. Vidal |
|
| International Journal of Molecular Sciences. 2021; 22(18): 9839 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
43 |
Nanoparticle-Guided Brain Drug Delivery: Expanding the Therapeutic Approach to Neurodegenerative Diseases |
|
|
| Claudia Riccardi, Filomena Napolitano, Daniela Montesarchio, Simone Sampaolo, Mariarosa Anna Beatrice Melone |
|
| Pharmaceutics. 2021; 13(11): 1897 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
44 |
Frequency and predictors of potential drug: Drug interactions in hospitalized patients with Parkinson's diseases |
|
|
| Dejan Aleksic, Srdan Stefanovic, Miloš Milosavljevic, Jovana Milosavljevic, Slobodan Jankovic |
|
| Hospital Pharmacology - International Multidisciplinary Journal. 2021; 8(3): 1099 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
45 |
The Correlation Between Parkinson’s Disease and Rapid Eye Movement Sleep Behavior Disorder: A Systematic Review |
|
|
| Niki Shrestha, Rose Anne M Abe, Anum Masroor, Arseni Khorochkov, Jose Prieto, Karan B Singh, Maduka C Nnadozie, Muhammad Abdal, Lubna Mohammed |
|
| Cureus. 2021; |
|
| [Pubmed] [Google Scholar] [DOI] |
|
46 |
Subcutaneous apomorphine in advanced Parkinson’s disease and its use in Indian population |
|
|
| Vinod Metta, Rupam Borgohain, Prashanth L Kukkle, Rukmini Mridula, Pankaj Agarwal, Asha Kishore, Vinay Goyal, Ray Chaudhuri |
|
| Annals of Movement Disorders. 2020; 3(3): 145 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
47 |
Natural Approaches for Neurological Disorders—The Neuroprotective Potential of Codium tomentosum |
|
|
| Joana Silva, Alice Martins, Celso Alves, Susete Pinteus, Helena Gaspar, Amparo Alfonso, Rui Pedrosa |
|
| Molecules. 2020; 25(22): 5478 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
48 |
Distinctive Evidence Involved in the Role of Endocannabinoid Signalling in Parkinson’s Disease: A Perspective on Associated Therapeutic Interventions |
|
|
| Tapan Behl, Gagandeep Kaur, Simona Bungau, Rishabh Jhanji, Arun Kumar, Vineet Mehta, Gokhan Zengin, Roxana Brata, Syed Shams ul Hassan, Ovidiu Fratila |
|
| International Journal of Molecular Sciences. 2020; 21(17): 6235 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
49 |
Substantia Nigra Hyperechogenicity Reflects the Progression of Dopaminergic Neurodegeneration in 6-OHDA Rat Model of Parkinson’s Disease |
|
|
| Siyan Zhang, Kai Tao, Jia Wang, Yunyou Duan, Bao Wang, Xi Liu |
|
| Frontiers in Cellular Neuroscience. 2020; 14 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
50 |
Curcumin and neurological diseases |
|
|
| Raffaella Adami, Daniele Bottai |
|
| Nutritional Neuroscience. 2020; : 1 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
51 |
Development and characterization of an inducible Dicer conditional knockout mouse model of Parkinson’s disease: validation of the antiparkinsonian effects of a sigma-1 receptor agonist and dihydromyricetin |
|
|
| Chen-hong Guo, Ting Cao, Long-tai Zheng, John L Waddington, Xue-chu Zhen |
|
| Acta Pharmacologica Sinica. 2020; 41(4): 499 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
52 |
The potential role of metformin in the treatment of Parkinson's disease |
|
|
| Mengnan Lu, Huangtao Chen, Fayi Nie, Xinyi Wei, Zhiwei Tao, Jie Ma |
|
| Journal of Bio-X Research. 2020; 3(1): 27 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
53 |
Neuroprotective Activity of Protocatechuic Acid (3,4-Dihydroxybenzoic Acid) to Treat Parkinson’s Disease |
|
|
| Jagatheesh Kaliaperumal, Satguru Dulari, Pandurangan A. , Mahendra Singh Rathore, Amit Mittal, Md. Shamshir Alam |
|
| Journal of Evolution of Medical and Dental Sciences. 2020; 9(34): 2466 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
54 |
Nörodejeneratif Hastalik Arastirmalarinda Drosophila melanogaster Modeli |
|
|
| Cem HAZIR, Gamze BORA, Hayat Erdem YURTER |
|
| Uludag Üniversitesi Tip Fakültesi Dergisi. 2020; |
|
| [Pubmed] [Google Scholar] [DOI] |
|
55 |
Dysregulation of the Gut-Brain Axis, Dysbiosis and Influence of Numerous Factors on Gut Microbiota Associated Parkinson’s Disease |
|
|
| Gagandeep Kaur, Tapan Behl, Simona Bungau, Arun Kumar, Md. Sahab Uddin, Vineet Mehta, Gokhan Zengin, Bijo Mathew, Muhammad Ajmal Shah, Sandeep Arora |
|
| Current Neuropharmacology. 2020; 19(2): 233 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
56 |
Orally Administered Nanotherapeutics For Parkinson’s Disease: An Old Delivery System Yet More Acceptable |
|
|
| Nidhi Aggarwal, Zufika Qamar, Saleha Rehman, Sanjula Baboota, Javed Ali |
|
| Current Pharmaceutical Design. 2020; 26(19): 2280 |
|
| [Pubmed] [Google Scholar] [DOI] |
|